The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma

S. Di Matteo, L. Nevi, D. Costantini, D. Overi, G. Carpino, S. Safarikia, F. Giulitti, C. Napoletano, E. Manzi, A. M. De Rose, F. Melandro, M. Bragazzi, P. B. Berloco, F. Giuliante, G. Grazi, A. Giorgi, V. Cardinale, L. Adorini, E. Gaudio, D. Alvaro

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Agriculture & Biology